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Abstract
Deep generative models are attracting great attention as a new promising approach
for molecular design. All models reported so far are based on either variational au-
toencoder (VAE) or generative adversarial network (GAN). Here we propose a new
type model based on an adversarially regularized autoencoder (ARAE). It basically
uses latent variables like VAE, but the distribution of the latent variables is obtained
by adversarial training like in GAN. The latter is intended to avoid both inappropri-
ate approximation of posterior distribution in VAE and difficulty in handling discrete
variables in GAN. Our benchmark study showed that ARAE indeed outperformed con-
ventional models in terms of validity, uniqueness, and novelty per generated molecule.
We also demonstrated successful conditional generation of drug-like molecules with
ARAE for both cases of single and multiple properties control. As a potential real-
world application, we could generate EGFR inhibitors sharing the scaffolds of known
active molecules while satisfying drug-like conditions simultaneously.
1
ar
X
iv
:1
91
2.
05
61
7v
1 
 [p
hy
sic
s.c
he
m-
ph
]  
13
 N
ov
 20
19
Introduction
One of the prime goals of chemistry is to make novel molecules with desired properties for
various purposes. Inspired by the great success of deep generative models in computer vision
tasks,1,2 molecular generative models have emerged as a new promising approach for efficient
molecular design.3,4 Diverse models have been proposed for materials design and de novo drug
design with promising results.5–19 Their key idea is to estimate the distribution of molecules
for a specific purpose and then to sample unseen molecules with target properties from the
estimated distribution. So far, generative adversarial networks (GANs)2 and latent variable
models have been widely used for that purpose. GANs directly estimate the distribution of
true input data by adversarial training of a generator and a discriminator. On the other hand,
latent variable models such as variational autoencoders (VAEs)1 estimate the distribution
of latent variables corresponding to input data and generate new molecules by decoding
latent variables sampled. Furthermore, one can incorporate desired properties directly in the
generation process by estimating the conditional distribution of molecules involving specific
target properties.
For instance, ChemicalVAE5 is one of the latent variable models. Its latent space is jointly
trained with a deep neural network for prediction of a target property. As a result, molecules
with desired properties can be designed by optimizing the target property on the latent space.
The feasibility of molecular generative model demonstrated by ChemicalVAE triggered the
active development of various models with similar concepts.8,20,21 However, VAE-based mod-
els often produce unnatural molecules, leading to the low validity of generated molecules.11
That might be because a unknown posterior distribution is approximated by a given family
of surrogate distributions, but inappropriate approximation can cause latent variables being
decoded to unnatural molecules. Since GANs directly estimate the distribution of true input
data via adversarial training, they can avoid limitations arisen from such an approxima-
tion. ORGAN17 and MolGAN11 are prototypes of GAN-based molecular generative models.
Indeed, GAN-based models show much improved validity. In contrast to computer vision
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tasks, however, molecular structures are expressed by the discrete categorical representation
of atomic symbols. GAN-based models are troublesome to deal with such a discrete variable
because of difficulty in estimating their distribution. As a result, molecules generated by
ORGAN and MolGAN were not diverse, leading to low uniqueness.
Having considered the above facts, it seems desirable to selectively take each advantage
of GAN- and VAE-based models to accomplish both high validity and uniquness. For this
purpose, we propose to use the platform of adversarially regularized autoencoder (ARAE)22
for molecular design. This model is grounded on the spirit of latent variable models that
transform the discretized input of molecular structures to continuous latent representations.
The key distinct feature of this model is to adopt the adversarial training used in GANs
to estimate the distribution of latent variables, which makes it avoid the problem caused
by the posterior approximation. As a result, one can achieve a high valid rate as well as
high uniqueness in molecular generation. For conditional generation, we disentangle the
information of molecular properties from latent vectors. Then, the target molecular properties
are injected independently with latent vectors into the decoder. Thus, we could produce
unseen molecules having the designated molecular properties with a high success rate.
We demonstrate the usefulness of our model with the following examples:
• We verify the high performance of our model in estimating a latent vector distribution
by showing the validity, uniqueness, and novelty of generated molecules. We also test
smoothness of latent space by interpolating between two vectors in the latent space.
• We show the feasibility of the simultaneous control of multiple properties with a high
success rate.
• As a possible practical application, we demonstrate that our model can be used for de
novo design of hit compounds in drug discovery with the example of epidermal growth
factor receptor (EGFR) inhibitors.
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Previous works
To compare ARAE with GAN and VAE and its technical advantages for molecular applica-
tions, we briefly introduce about each method. Then, we describe our implementation of the
ARAE modified for molecular generations in detail.
Generative adversarial network
GANs2 estimate the distribution of input samples, pr(x), through the adversarial training of
a generator network and a discriminator network. By taking a random variable s drawn from
a prior distribution p(s), the generator gψ parameterized by ψ produces new samples gψ(s) of
the distribution pg(x). To estimate the distribution of true data by generating samples with
the generator, Wassestein GAN is used to minimize the gap between the true and generated
distributions (pr(x) and pg(x), respectively).
23 Thus, the training objective is given by
min
ψ
W(pr, pg) = min
ψ
max
w
Ex∼pr(x)[fw(x)]− Es∼p(s)[fw(gψ(s))], (1)
where fw is a discriminator (critic) function parameterized by w satisfying the 1-Lipschtiz
continuity ‖fw‖ ≤ 1. As a result of the adversarial training of these two networks, the
distributions of data samples pr(x) and of generated samples pg(x) become equivalent, i.e.,
pr(x) = pg(x).
Learning discretized representations such as molecular structures with GANs often fails
because outputs can be easily degenerated into training data.22,24 This drawback causes low
efficiency for the generation of unseen molecules with GAN-based models.
Variational autoencoder
Instead of directly modeling the distribution of input data, latent variable models infer the
distribution of latent variables (the posterior). However, it is intractable to find an exact
posterior distribution in most cases. VAEs approximate the posterior distribution with the
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variational distribution qθ(z|x) which is an output of the encoder parameterized with θ,
given an input x, and the decoder parameterized by φ reconstructs the inputs from the
latent variables drawn from the posterior.1 The minimization objective of VAEs is given by
min
θ,φ
Ex∼pr(x)[Lrec(θ, φ) + KL(qθ(z|x)||p(z))], (2)
where Lrec(θ, φ) = Eqθ(z|x)[− log pφ(x|z)] is the reconstruction loss and KL(qθ(z|x)||p(z)) is
the Kullback-Leiber (KL) divergence between the variational distribution qθ(z|x) and the
prior distribution p(z). Minimizing the second term makes the two distributions as similar
as possible. Hence, the posterior distribution can be approximated by imposing it on the
prior distribution.
Since VAEs approximate the posterior distribution with a predefined prior (a surrogate
family of distributions), they can readily estimate the distribution of latent variables. How-
ever, the drawback of using the VAEs is well-known; a latent space can have holes in which
latent vectors are not matched to true data points.25 That causes the generation of chem-
ically unrealistic molecules.5 The main reasons of the hole existing problem are as follows.
First, the true posterior distribution may not be well approximated by a given prior, such as
a normal distribution. Second, minimizing the KL-divergence between two distributions is
not suitable if the posterior distribution is multi-modal.26,27 In such cases, using VAEs may
not be a good approach to model a latent variable distribution.
Adversarially regularized autoencoder
The ARAE method was proposed to address the aforementioned problems of the GANs
and the VAEs.22 It is basically a latent variable model which adopts an encode-decoder
architecture, but the posterior distribution is estimated by adversarial training. The encoder
network parameterized by θ outputs the distribution of true latent variables z = encθ(x) ∼
pθ(z) from the given inputs. The decoder network parameterized by φ reconstructs the input
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from the latent variable drawn from the posterior. By following the idea of GANs, the
generator parmeterized by ψ outputs the distribution of generated random variables z˜ =
gψ(s) ∼ pψ(z˜), where s is a random variable drawn from the prior distribution p(s). Since
ARAE aims to estimate the posterior distribution by generating a similar distribution with
that of the generator, the training objective is given by
min
θ,φ,ψ
Ex∼pr(x)[Lrec(θ, φ) + W(pθ(z), pψ(z˜))], (3)
where the reconstruction loss is written as
Lrec(θ, φ) = Ez∼pθ(z)[− log pφ(x|z)] (4)
and the Wasserstein-1 distance between the two distributions is written as
W(pθ(z), pψ(z˜)) = max
w
Ez∼pθ(z)[fw(z)]− Ez˜∼pψ(z˜)[fw(z˜)], (5)
with the 1-Lipschtiz continuity ‖fw‖ ≤ 1. As a result of training, the two distributions pθ and
pψ become identical, and we can generate new samples by using random variables sampled
from pψ as an input to the decoder.
Methods
We devised a new type of molecular generative model by adopting the architecture of ARAE.
The SMILES representation of molecular structure is adopted as a discrete random variable
input to the model. The raw input is first transformed to the latent representation, and its
distribution is estimated by adversarial training. As we discussed in the previous section,
this approach has the following advantages. First, it can avoid the hole-generating problem
appeared in VAEs by estimating the posterior through adversarial training. As a result, the
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Figure 1: The architecture of CARAE for molecular generations. The encoder embeds the
SMILES representation of molecular structure x to the latent vector z, and the decoder
reconstructs the molecular structures from the latent vector. As a result of the adversarial
training, two distributions pθ(z) and pψ(z˜) become equivalent. The predictor is trained to
predict an original molecular property y and separate this information from the latent vector
by minimizing the mutual information term in eq. (7). In decoding phase, the specified
property information yc is incorporated together with the latent vector to generate the
molecules with specific desired property.
valid rate of generated molecules is expected to be high. Second, it improves a low learning
ability of GANs for discrete representation like SMILES by using continuous latent variables
in the adversarial training.
In addition, we introduced an efficient conditional generation scheme of molecules. The
key idea of conditional generative model is to estimate the distribution of data samples as
latent vectors and conditions are jointly given: p(x|z,yc). However, the latent vectors, which
are supposed to correspond to molecular structures, would not be independent from target
molecular properties. To control the target properties and structures in parallel, therefore,
we design a model so as to disentangle the property information from the latent vectors. To
do so, we jointly minimize the mutual information MI(z,y; θ, λ) which means the amount of
the information of a target property y obtained from the latent vector z. Since an exact value
of the mutual information is not known, we compute the variational mutual information28,29
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given by
MI(z,y; θ, λ) = H(y)− H(y|z)
= Ez∼pθ(z)[Ey∼p(y|z) log p(y|z)] + H(y)
= Ez∼pθ(z)[KL(p(y|z)||qλ(y|z)) + Ey∼p(y|z)[log qλ(y|z)]] + H(y)
≥ Ez∼pθ(z)[Ey∼p(y|z)[log qλ(y|z)]] + H(y),
(6)
where H(y) denotes the marginal entropy, H(y|z) is the joint entropy of y and z, and qλ(y|z)
is the auxiliary conditional distribution of y for the given z, which is estimated by the
predictor parameterized by λ. As done in the previous work,29 we also consider H(y) as a
constant. Therefore, we set the training objective as follows:
min
θ,φ,ψ
Ex∼pr(x)[Lrec(θ, φ) + W(pθ(z), pψ(z˜)) + VMI(y, z; θ, λ)], (7)
where VMI(y, z; θ, λ) = maxλ Ez∼pθ(z)[Ey∼p(y|z)[log qλ(y|z)]]. We note that minimizing the
third term makes the property information separated from the latent vector. In the decoding
phase, the target property information yc, which acts as a condition vector for the recon-
struction of molecules, is given together with the latent vector of query molecule z. As a
result, molecules with designated properties can be generated with independent structural
control. We term this model as ‘conditional ARAE (CARAE)’ hereafter.
Figure 1 illustrates the architecture of the CARAE model for molecular generations.
SMILES seqeunces are transformed by the encoder into latent variables. The generator pro-
duces new samples by taking random variables from a distribution N (0, σ2I). Then, the
distributions of those two variables become as similar as possible by minimizing the first and
the second term of eq. (7) with gradient descent optimization. For the CARAE model, we
add the predictor network which is used to estimate the variational mutual information term,
the third term in eq. (7). In the training phase, the decoder reconstructs input molecular
structures from the latent vector and property information of input molecules. In the test
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phase, we can sample new molecules by tuning the latent vector which is drawn from pψ(z˜)
and by specifying the desired property yc.
Results and discussion
To train and test our model, we used the QM9 and ZINC datasets. The QM9 set contains
133,885 small organic molecules with up to nine heavy atoms.30 The ZINC set used in this
work is same with that used in training ChemicalVAE,5 which consists of 249,455 molecules
randomly selected from the drug-like subset of the ZINC database.31
Before explaining experimental results, we introduce the metrics used to evaluate the
performance of our model as follows:
• Validity: the ratio of the number of valid molecules to the number of generated sam-
ples. The validity was checked by using RDKit.32
• Uniqueness: the ratio of the number of unrepeated molecules to the number of valid
molecules.
• Novelty: the ratio of the number of molecules which are not included in the training
set to the number of unique molecules.
• Novel/Sample: the ratio of the number of valid, unique, and novel molecules to the
total number of generated samples.
Performance of ARAE on molecular generation
Training a generative model based on GANs is often unstable. Hence, we first investigated
using the QM9 dataset how each evaluation metric changes as the training of our model
progresses. After each epoch, 10,000 samples were generated, and the four metrics (validity,
uniqueness, novelty, and novel/sample) were calculated. Figure 2 shows the result of the first
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Figure 2: Convergence of the four evaluation metrics for the ARAE model trained with the
QM9 dataset.
Table 1: Performance of benchmark models and our model for the QM9 dataset. Baseline
results are taken from De Cao et al.11 We also show the performance of our model for the
ZINC dataset in the bottom row.
Method Validity (A) Uniqueness (B) Novelty (C) Novel/Sample (A×B×C)
ChemicalVAE 0.103 0.675 0.900 0.063
GrammarVAE 0.602 0.093 0.809 0.045
GraphVAE 0.557 0.670 0.616 0.261
GraphVAE/imp 0.562 0.520 0.758 0.179
GraphVAE NoGM 0.810 0.241 0.610 0.129
MolGAN 0.981 0.104 0.942 0.096
ARAE 0.862 0.935 0.371 0.299
ARAE (ZINC) 0.903 1.000 1.000 0.903
80 epochs. All evaluation metrics were smoothly converged, indicating that common difficul-
ties in training GANs such as mode collapse or diminished gradient are less problematic in
our model.
We also compare the performance of ARAE to those of ChemicalVAE,5 GrammarVAE,20
GraphVAE,33 and MolGAN.11 For an input molecular representation, ChemicalVAE and
GrammarVAE used SMILES, while GraphVAE and MolGAN adopted molecular graphs.
Table 1 summarizes the validity, uniqueness, novelty, and novel/sample of each model. All
the models were trained by using the QM9 dataset. Overall, ARAE outperformed the others
except for novelty.
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Figure 3: Molecules reconstructed from the latent vectors that appeared in the interpolation
among two latent vectors. The starting and ending points are the latent vectors of Aspirin
and Tamiflu, respectively.
As intended, it significantly improved the validity and uniqueness from those of the VAE-
based and MolGAN models, respectively, by taking the advantages of both methods. The
relative low novelty value is due to the low chemical diversity of the QM9 dataset in which
molecules are composed of less than ten heavy atoms. This limited number of heavy atoms
restricts opportunities to generate novel molecules. On the other hand, ARAE could achieve
high novelty for the ZINC dataset (the bottom low of Table 1), because the ZINC dataset
spans a huge chemical space. This result further supports the reason of the low novelty of
ARAE for QM9. Though MolGAN also adopted the adversarial training, it showed a high
novelty value but by sacrificing the uniqueness, meaning that a high value on one metric can
be achieved by sacrificing the others. Therefore, the ratio of novel molecules among generated
samples (novelty/sample) is a more practical metric for performance comparison. Models
using graph representation showed relatively higher novel/sample values than models using
SMILES. ARAE achieved the highest value of novel/sample in spite of using the SMILES
representation.
One of the major drawbacks of VAE-based generative models is the presence of holes
in the latent space due to the approximated posterior, resulting in low validity as noted in
Table 1. This problem can often cause the generation of unrealistic molecules at interpolation
points between two latent vectors. In contrast, adversarial training does not impose any
analytic form of the posterior. Therefore, it is expected that ARAE can avoid such a problem.
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To demonstrate the successful modeling of latent space with the adversarial training, we
attempted to generate molecules through an interpolation experiment as shown in Figure
3. We obtained 100 latent vectors by linearly interpolating the two seed vectors obtained
from Aspirin sa and Tamiflu sb. Then, each sampled vector was decoded to generate the
corresponding molecule. All the 100 latent vectors successfully generated valid molecules,
and 19 molecules out of them were unique and novel. Figure 3 exhibits 6 examples showing
smooth change from Aspirin to Tamiflu. We also note that high-membered ring molecules
which often appear in VAE-based molecular generative models5,20 were not produced by our
model.
Conditional generation of molecules with CARAE
Figure 4: Distributions of molecular property - (a) logP, (b) SAS and (c) TPSA - when
molecules are generated by specifying a desired property. Note that the curves labeled with
ZINC denote the distribution of each molecular property in the ZINC dataset.
In this section, we examine the performance of our model for conditional generation of
molecules. First, we tested that CARAE can generate molecules with high validity, unique-
ness, novelty, and diversity as ARAE does. The performance of CARAE may depend on
designated property values, so we compared the performance of CARAE for both random
property values and certain designated ones. Three properties (logP, SAS, and TPSA) were
controlled simultaneously. Table 2 summarizes the validity, uniqueness, novelty, and diversity
of ARAE and CARAE, where both models were trained using the ZINC dataset. CARAE
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shows comparable performance with that of ARAE except for the high SAS value (5.0). Since
the SAS value is related to synthetic accessibility and structural stability, the frequency of
valid molecules would be low at a high SAS value. The high success rates of the condi-
tional generation are an evidence that the latent space was well separated from multiple
target properties, and hence one can readily control molecular structures under given fixed
multiple conditions.
Table 2: Performance of ARAE and CARAE trained with ZINC dataset. The diversity of the
ZINC testset is 0.915. In this work, we disentangled the information of molecular properties
(logP, SAS and TPSA) from latent vectors and incorporated target properties in it later as
a condition vector, yc.
† For the ‘CARAE, random’, we randomly chose molecular property
values and incorporated them in the latent vectors of molecules in the ZINC dataset. ‡ For
the ‘CARAE, (·, ·, ·)’, we used molecular property values drawn from a Gaussian distribution
N(·, 1.0).
Method and Condition Validity Uniqueness Novelty Diversity
ARAE 0.903 1.000 1.000 0.909
CARAE, random† 0.812 1.000 1.000 0.911
CARAE, (1.5, 2.0, 30)‡ 0.897 0.926 0.998 0.894
CARAE, (1.5, 2.0, 100) 0.823 0.996 1.000 0.890
CARAE, (1.5, 5.0, 30) 0.860 0.997 1.000 0.914
CARAE, (1.5, 5.0, 100) 0.573 1.000 1.000 0.909
CARAE, (4.5, 2.0, 30) 0.908 0.995 1.000 0.900
CARAE, (4.5, 2.0, 100) 0.813 1.000 1.000 0.884
CARAE, (4.5, 5.0, 30) 0.621 1.000 1.000 0.912
CARAE, (4.5, 5.0, 100) 0.293 1.000 1.000 0.911
We investigated how accurate the target properties of molecules generated by CARAE
are. The conditional generator produced 10,000 molecules with a given target property.
Figure 4 compares the normalized frequency of the conditionally-generated molecules for
each property and the natural population of the ZINC set molecules; molecular properties
for both cases were computed by RDKit. The logP values of the generated molecules were
well localized around the designated values denoted in each panel. The SAS and TPSA values
showed relatively broader distributions, but compared to the natural populations, they were
also very localized around the given targets. Figure 5 shows the distributions of molecules
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generated with the simultaneous control of three target properties. Indeed, each distribution
was well localized around a given designated point and well separated from each other. These
results indicate the high accuracy of our CARAE model for multiple property control as well.
Figure 5: Joint distribution of the logP, SAS and TPSA values of molecules generated with
the simultaneous control of the three target properties denoted in the legend.
de novo design of EGFR inhibitors
Molecular generative models have attracted attention as a promising solution for de novo
molecular design for new drugs or materials. To demonstrate the utility of our model, we
applied it to designing novel inhibitors of an epidermal growth factor receptor (EGFR). We
obtained active and decoy molecules from the DUD-E database and trained the CARAE
model with four target properties: activity against EGFR, logP, TPSA, and SAS. Inhibitors
were then generated according to the following two scenarios:
• Generation with only activity condition: activity = 1. We aimed to generate EGFR-
active molecules only.
• Generation with the four conditions: activity = 1, logP = 2.5, SAS = 1.5, and TPSA
= 60. It was intended to generate molecules satisfying the Lipinski’s rule of five34 and
synthesizability.
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Figure 6: Five generated EGFR inhibitors (A) without additional condition and (B) with
additional condition of ’logP = 2.5, SAS = 1.5 and TPSA = 60’.
For both scenarios, we analyzed the scaffolds of the generated valid molecules from 3,500
trials to validate them. We used the method proposed by Bemis and Murcko35 to extract
the scaffolds of molecules. As a result, we could generate new drug candidates with known
active scaffolds. From the first scenario, 931 new molecules were obtained and 195 molecules
out of them shared the scaffolds of known active molecules. From the second scenario, 1,067
new molecules were obtained, 88 molecules out of them shared the scaffolds of known active
molecules and satisfy the additional conditions. Molecules with 1.5 < LogP < 3.5, 0.5 < SAS
< 2.5, and 50 < TPSA < 70 were considered to satisfy the additional conditions. The number
of successful molecules was decreased in the second scenario because the additional conditions
impose more strict constraints than the first scenario. Figure 6 shows five molecules obtained
from each scenario as examples.
Conclusions
Conventional molecular generative models are based on either variational autoencoder (VAE)
or generative adversarial network (GAN). The former often produces invalid molecules due
to hole areas in the latent space arisen from an inappropriate approximation of posterior dis-
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tribution. The latter estimates the distribution directly from input data through adversarial
training, leading to enhanced validity. However, it is problematic in training discrete vari-
ables such as molecular structures, resulting in the low uniqueness of generated molecules. To
address such challenges, we newly propose a molecular generative model built on adversari-
ally regularized autoencoder (ARAE). It is based on a latent variable model like VAE, but
the distribution of latent variables is obtained by adversarial training directly from training
data like in GAN instead of approximating with a predefined function. Furthermore, it uses
continuous latent vectors instead of discrete molecular structures in the adversarial training
in order to avoid the difficulty in dealing with discrete variables. Based on these facts, it
could take the advantages of both VAE and GAN to overcome the limitations of each model.
The benchmark studies in this work provide numerical evidences of the high performance
of our ARAE model for molecular generations. First, it outperformed other VAE-based and
GAN-based models in terms of the uniqueness and the novel/sample-ratio still with high
validity for the QM9 data set. It also allows smooth interpolation between two molecules in
the latent space, which shows the feasibility of the successful modeling of latent space via
adversarial training. Conditional generation of molecules with specific target properties was
demonstrated as well. Target molecular properties are first disentangled from latent vectors,
and desired values are incorporated in the latent vectors to independently control molecular
structure and properties. Our model showed good performance in conditional generations
for both cases of single and multiple properties control. To demonstrate potential real-world
applications, we applied the conditional generation scheme to designing EGFR-inhibitors.
We could successfully generate new candidate molecules while satisfying drug-like conditions
simultaneously.
Consequently, we believe that ARAE can be a new platform for AI-based molecular
design in various chemical applications.
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Implementation details
We summarize the configuration of our model in Table 3. Each of the encoder and the decoder
is composed of a single LSTM layer, and the dimensionality of outputs is 300. The LSTM
layer of the encoder reads sequential SMILES strings and transforms them to latent vectors.
For adversarial training, we use two fully-connected layers with a hidden dimension of 300 for
ZINC (200 for QM9) for the generator and the discriminator networks. The predictor network
is also composed of two fully-connected layers with a hidden dimension 300 for ZINC (200
for QM9). We uploaded our code on github https://github.com/gicsaw/ARAE_SMILES.
Table 3: Configuration of the model used in this work. Note that the predictor is only used
for conditional generations with CARAE.
Layer configuration Nonlinearity Dimension (QM9) Dimension (ZINC)
Encoder One LSTM layer - 200 300
Decoder One LSTM layer + Softmax layer - 200 300
Generator Two fully-connected layers ReLU 200 300
Discriminator Two fully-connected layers LReLU 200 300
Predictor Two fully-connected layers ReLU - 300
Table 4 describes the hyperparameters and the optimizers of ARAE.
Table 4: Optimizers and prarameters of ARAE.
Variable parameters Optimizer Learning rate
Auto-Encoder Encoder and Decoder SGD 1.0
Generator Generator Adam 1.0× 10−5
Critic Critic Adam 2.0× 10−6
Predictor Predictor Adam 1.0
Disentanglement Encoder Adam 1.0
Acknowledgements
This work was supported by the National Research Foundation of Korea (NRF) grant funded
by the Korea government (MSIT)(NRF-2017R1E1A1A01078109).
17
Author contributions
J.L., S.R. and W.Y.K. conceived the idea, J.L. and S.H.H. did the implementation and run
the simulation. All the authors analyzed the results and wrote the manuscript together.
Conflicts of interest
The authors declare no competing financial interests.
References
(1) Kingma, D. P.; Welling, M. Auto-encoding variational bayes. arXiv preprint
arXiv:1312.6114 2013,
(2) Goodfellow, I.; Pouget-Abadie, J.; Mirza, M.; Xu, B.; Warde-Farley, D.; Ozair, S.;
Courville, A.; Bengio, Y. Generative adversarial nets. Advances in neural information
processing systems. 2014; pp 2672–2680.
(3) Chen, H.; Engkvist, O.; Wang, Y.; Olivecrona, M.; Blaschke, T. The rise of deep learning
in drug discovery. Drug Discovery Today 2018, 23, 1241–1250.
(4) Sanchez-Lengeling, B.; Aspuru-Guzik, A. Inverse molecular design using machine learn-
ing: Generative models for matter engineering. Science 2018, 361, 360–365.
(5) Go´mez-Bombarelli, R.; Wei, J. N.; Duvenaud, D.; Herna´ndez-Lobato, J. M.; Sa´nchez-
Lengeling, B.; Sheberla, D.; Aguilera-Iparraguirre, J.; Hirzel, T. D.; Adams, R. P.;
Aspuru-Guzik, A. Automatic chemical design using a data-driven continuous represen-
tation of molecules. ACS central science 2018, 4, 268–276.
(6) Segler, M. H.; Kogej, T.; Tyrchan, C.; Waller, M. P. Generating focused molecule li-
18
braries for drug discovery with recurrent neural networks. ACS central science 2017,
4, 120–131.
(7) Popova, M.; Isayev, O.; Tropsha, A. Deep reinforcement learning for de novo drug
design. Science advances 2018, 4, eaap7885.
(8) Lim, J.; Ryu, S.; Kim, J. W.; Kim, W. Y. Molecular generative model based on
conditional variational autoencoder for de novo molecular design. arXiv preprint
arXiv:1806.05805 2018,
(9) Li, Y.; Zhang, L.; Liu, Z. Multi-Objective De Novo Drug Design with Conditional Graph
Generative Model. arXiv preprint arXiv:1801.07299 2018,
(10) You, J.; Liu, B.; Ying, R.; Pande, V.; Leskovec, J. Graph Convolutional Policy Network
for Goal-Directed Molecular Graph Generation. arXiv preprint arXiv:1806.02473 2018,
(11) De Cao, N.; Kipf, T. MolGAN: An implicit generative model for small molecular graphs.
arXiv preprint arXiv:1805.11973 2018,
(12) Gupta, A.; Mu¨ller, A. T.; Huisman, B. J.; Fuchs, J. A.; Schneider, P.; Schneider, G.
Generative Recurrent Networks for De Novo Drug Design. Molecular Informatics 2018,
37 .
(13) Bjerrum, E.; Sattarov, B. Improving Chemical Autoencoder Latent Space and Molec-
ular De Novo Generation Diversity with Heteroencoders. Biomolecules 2018, 8, 131.
(14) Ikebata, H.; Hongo, K.; Isomura, T.; Maezono, R.; Yoshida, R. Bayesian molecular
design with a chemical language model. Journal of Computer-Aided Molecular Design
2017, 31, 379–391.
(15) Kang, S.; Cho, K. Conditional Molecular Design with Deep Generative Models. Journal
of Chemical Information and Modeling 2019, 59, 43–52.
19
(16) Polykovskiy, D.; Zhebrak, A.; Vetrov, D.; Ivanenkov, Y.; Aladinskiy, V.; Mamoshina, P.;
Bozdaganyan, M.; Aliper, A.; Zhavoronkov, A.; Kadurin, A. Entangled Conditional
Adversarial Autoencoder for de Novo Drug Discovery. Molecular Pharmaceutics 2018,
15, 4398–4405, PMID: 30180591.
(17) Guimaraes, G. L.; Sanchez-Lengeling, B.; Outeiral, C.; Farias, P. L. C.; Aspuru-
Guzik, A. Objective-reinforced generative adversarial networks (ORGAN) for sequence
generation models. arXiv preprint arXiv:1705.10843 2017,
(18) Olivecrona, M.; Blaschke, T.; Engkvist, O.; Chen, H. Molecular De Novo Design through
Deep Reinforcement Learning. Journal of Cheminformatics 2017, 9, 1–14.
(19) Neil, D.; Segler, M.; Guasch, L.; Ahmed, M.; Plumbley, D.; Sellwood, M.; Brown, N.
Exploring Deep Recurrent Models with Reinforcement Learning for Molecule Design.
2018,
(20) Kusner, M. J.; Paige, B.; Herna´ndez-Lobato, J. M. Grammar Variational Autoencoder.
International Conference on Machine Learning. 2017; pp 1945–1954.
(21) Kang, S.; Cho, K. Conditional molecular design with deep generative models. Journal
of chemical informatiion and modeling 2018,
(22) Zhao, J. J.; Kim, Y.; Zhang, K.; Rush, A. M.; LeCun, Y. Adversarially Regularized
Autoencoders. arXiv preprint arXiv:1706.04223 2017,
(23) Arjovsky, M.; Chintala, S.; Bottou, L. Wasserstein gan. arXiv preprint
arXiv:1701.07875 2017,
(24) Kusner, M. J.; Herna´ndez-Lobato, J. M. Gans for sequences of discrete elements with
the gumbel-softmax distribution. arXiv preprint arXiv:1611.04051 2016,
(25) Makhzani, A.; Shlens, J.; Jaitly, N.; Goodfellow, I.; Frey, B. Adversarial autoencoders.
arXiv preprint arXiv:1511.05644 2015,
20
(26) Murphy, K. P. Machine learning: a probabilistic perspective; MIT press, 2012.
(27) Goodfellow, I. NIPS 2016 tutorial: Generative adversarial networks. arXiv preprint
arXiv:1701.00160 2016,
(28) Agakov, D. B. F. The IM algorithm: a variational approach to information maximiza-
tion. Advances in Neural Information Processing Systems 2004, 16, 201.
(29) Chen, X.; Duan, Y.; Houthooft, R.; Schulman, J.; Sutskever, I.; Abbeel, P. Infogan:
Interpretable representation learning by information maximizing generative adversarial
nets. Advances in neural information processing systems. 2016; pp 2172–2180.
(30) Ramakrishnan, R.; Dral, P. O.; Rupp, M.; Von Lilienfeld, O. A. Quantum chemistry
structures and properties of 134 kilo molecules. Scientific data 2014, 1, 140022.
(31) Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. ZINC: a free
tool to discover chemistry for biology. Journal of chemical information and modeling
2012, 52, 1757–1768.
(32) others,, et al. RDKit: Open-source cheminformatics. 2006.
(33) Simonovsky, M.; Komodakis, N. GraphVAE: Towards Generation of Small Graphs Us-
ing Variational Autoencoders. arXiv preprint arXiv:1802.03480 2018,
(34) Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and com-
putational approaches to estimate solubility and permeability in drug discovery and
development settings1PII of original article: S0169-409X(96)00423-1. The article was
originally published in Advanced Drug Delivery Reviews 23 (1997) 3??5.1. Advanced
Drug Delivery Reviews 2001, 46, 3 – 26, Special issue dedicated to Dr. Eric Tomlin-
son, Advanced Drug Delivery Reviews, A Selection of the Most Highly Cited Articles,
1991-1998.
21
(35) Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 1. Molecular Frame-
works. Journal of Medicinal Chemistry 1996, 39, 2887–2893, PMID: 8709122.
22
Graphical TOC Entry
Some journals require a graphical entry for the Table of Contents. This
should be laid out “print ready” so that the sizing of the text is correct.
Inside the tocentry environment, the font used is Helvetica 8 pt, as re-
quired by Journal of the American Chemical Society.
The surrounding frame is 9 cm by 3.5 cm, which is the maximum per-
mitted for Journal of the American Chemical Society graphical table of
content entries. The box will not resize if the content is too big: instead
it will overflow the edge of the box.
This box and the associated title will always be printed on a separate
page at the end of the document.
23
